These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 8518602)

  • 1. Cholesterol lowering and mortality: the importance of considering initial level of risk.
    Smith GD; Song F; Sheldon TA
    BMJ; 1993 May; 306(6889):1367-73. PubMed ID: 8518602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease.
    Marchioli R; Marfisi RM; Carinci F; Tognoni G
    Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials.
    Pignone M; Phillips C; Mulrow C
    BMJ; 2000 Oct; 321(7267):983-6. PubMed ID: 11039962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholesterol-lowering treatment on coronary heart disease morbidity and mortality: the evidence from trials, and beyond.
    Katan MB
    Cardiology; 1990; 77 Suppl 4():8-13. PubMed ID: 2073675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
    Ramsden CE; Zamora D; Majchrzak-Hong S; Faurot KR; Broste SK; Frantz RP; Davis JM; Ringel A; Suchindran CM; Hibbeln JR
    BMJ; 2016 Apr; 353():i1246. PubMed ID: 27071971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lipid-lowering therapy on total and coronary mortality.
    Holme I
    Curr Opin Lipidol; 1995 Dec; 6(6):374-8. PubMed ID: 8750251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome.
    Ravnskov U
    BMJ; 1992 Jul; 305(6844):15-9. PubMed ID: 1638188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease.
    Ebrahim S; Smith GD
    BMJ; 1997 Jun; 314(7095):1666-74. PubMed ID: 9193292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lipid lowering therapy for primary prevention of coronary heart disease--contra lipid lowering therapy].
    Berger M
    Z Kardiol; 1998; 87 Suppl 2():210-3. PubMed ID: 9827485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [All mortality by cause of death. The challenge of coronary prevention].
    Fernández-Cruz A
    Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol lowering and the reduction of CHD incidence and total mortality: results from a meta-analysis of randomized trials.
    Holme I
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):101-2. PubMed ID: 1390319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering treatment in coronary artery disease: how low should cholesterol go?
    Jones PH
    Drugs; 2000 May; 59(5):1127-35. PubMed ID: 10852644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials.
    Gould AL; Davies GM; Alemao E; Yin DD; Cook JR
    Clin Ther; 2007 May; 29(5):778-794. PubMed ID: 17697899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol reduction yields clinical benefit. A new look at old data.
    Gould AL; Rossouw JE; Santanello NC; Heyse JF; Furberg CD
    Circulation; 1995 Apr; 91(8):2274-82. PubMed ID: 7697857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of coronary heart disease through cholesterol reduction.
    Grundy SM
    Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol screening in asymptomatic adults, revisited. Part 2.
    Garber AM; Browner WS; Hulley SB
    Ann Intern Med; 1996 Mar; 124(5):518-31. PubMed ID: 8602715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future of lipid-lowering trials: what else do we need to know?
    Jones PH
    Am J Cardiol; 1998 Sep; 82(6A):32M-38M. PubMed ID: 9766346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.